Reccurent painful ophthalmoplegic neuropathy
https://doi.org/10.30629/2658-7947-2022-27-6-77-83
Abstract
Reccurent painful ophthalmoplegic neuropathy (the Tolosa–Hunt syndrome) occurs due to a nonspecific granulomatous infl ammation of the walls of the cavernous sinus and the intracavernous segment of the internal carotid artery. It consists of one or more oculomotor nerves dysfunction associated with peri- and retroorbital pain; spontaneous remissions and relapses are typical. Oculomotor nerve disorders may coincide with the onset of pain or follow it within a period of up to 2 weeks. Demonstration of granulomatosis in the walls of the cavernous sinus and the intracavernous segment of the internal carotid artery, superior orbital fissure or orbit by MRI or biopsy confi rms the diagnosis of Tolosa–Hunt syndrome (THS). Corticosteroid therapy leads to rapid (within 72 hours) pain relief and recovery of oculomotor nerve function. Here, we report a case of reccurent THS in 47-year-old men. Neuroimaging schowed a nonspecific inflammation in the superior orbital fissure-cavernous sinus region on left side and contrast-enhanced thickening dura mater.
About the Authors
M. Yu. MaksimovaRussian Federation
Moscow
S. N. Illarioshkin
Russian Federation
Moscow
I. A. Savizkaya
Russian Federation
Moscow
References
1. Tolosa E. Periarteritic lesions of the carotid siphon with the clinical features of a carotid infraclinoidal aneurysm. J Neurol Neurosurg Psychiatry. 1954;17:300–2. https://doi.org/10.1136/jnnp.17.4.300
2. Hunt W.E., Meagher J.N., Lefever H.E., Zeman W. Painful opthalmoplegia. Its relation to indolent infl ammation of the cavernous sinus. Neurology. 1961;11:56–62. https://doi.org/10.1212/wnl.11.1.56
3. Lakke J.P. Superior orbital fi ssure syndrome. Report of a case caused by local pachymeningitis. Arch Neurol. 1962;7:289–300. https://doi.org/10.1001/archneur.1962.04210040041004
4. Smith J.L., Taxdal D.S. Painful ophthalmoplegia. The TolosaHunt syndrome. Am J Ophthalmol. 1966;61:1466–72. PMID: 5938314.
5. Ponomarev V.V. Tolosa–Hunt syndrome: defi nition, clinical, diagnostic, therapy. Meditsinskie novosti.2015;1:6–9. (In Russ.).
6. Ivanova-Smolenskaya I.A., Zakutnyaya V.N., Zakharova M.N., Krasnov M.Yu. A case of Tolosa– Hunt syndrome. Nervnye bolezni. 2013;1:20–22. (In Russ.).
7. Dutta P., Anand K. Tolosa–Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues. J Curr Ophthalmol. 2021;33(2):104-111. https://doi.org/10.4103/joco.joco_134_20
8. Ponomarev V.V. Sindrom Tolosa–Hanta: diff erencial'naya diagnostika. Foliant, 2016:220 p. (In Russ.).
9. Cakirer S. MRI fi ndings in the patients with the presumptive clinical diagnosis of Tolosa–Hunt syndrome. Eur Radiol. 2003;13(1):17–28. https://doi.org/10.1007/s00330-002-1458-3
10. Wani N.A., Jehangir M., Lone P.A. Tolosa–Hunt syndrome demonstrated by constructive interference steady state magnetic resonance imaging. J Ophthalmic Vis Res. 2017;12(1):106–9. https://doi.org/10.4103/2008-322X.200171
11. Colnaghi S., Pichiecchio A., Bastianello S., Versino M. SPIR MRI usefulness for steroid treatment management in Tolosa– Hunt syndrome. Neurol Sci. 2006;27(2):137–9. https://doi.org/10.1007/s10072-006-0616-9
12. Okawa S., Hanazono A., Sugawara M., Takahashi S., Otani T., Hanyu N. et al. Contrast-enhanced 3D FIESTA imaging in Tolosa–Hunt syndrome. Headache. 2012;52(5):822–4. https://doi.org/10.1111/j.1526-4610.2012.02089.x
13. Abdelghany M., Orozco D., Fink W., Begley C. Probable Tolosa– Hunt syndrome with a normal MRI. Cephalalgia. 2015;35:449– 52. https://doi.org/10.1177/0333102414539053
14. Hunt W.E., Brightman R.P. The Tolosa–Hunt syndrome: a problem in diff erential diagnosis. Acta Neurochir Suppl (Wien). 1988;42:248–52. https://doi.org/10.1007/978-3-7091-8975-7_48
15. Gladstone J.P. An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa–Hunt syndrome. Curr Pain Headache Rep. 2007;11(4):317–25. https://doi.org/10.1007/s11916-007-0211-7
16. Ponomarev V.V., Baranowskiy A.E., Sytyi Yu.V., Zaretskiy S.V. Head tumors simulating the Tolosa– Hunt syndrome. Annals of clinical and experimental neurology. 2015;9(2):12–17. (In Russ.).
17. Colnaghi S., Versino M., Marchioni E., Pichiecchio A., Bastianello S., Cosi V. et al. ICHD-II diagnostic criteria for Tolosa– Hunt syndrome in idiopathic infl ammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia. 2008;28(6):577–84. https://doi.org/10.1111/j.1468-2982.2008.01569.x
18. Hung C.H., Chang K.H., Wu Y.M., Chen Y.L., Lyu R.K., Chang H.S. et al. A comparison of benign and infl ammatory manifestations of Tolosa-Hunt syndrome.Cephalalgia. 2013;33(10):842–52. https://doi.org/10.1177/0333102412475238
19. Headache Classifi cation Committee of the International Headache Society (IHS) The International Classifi cation of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211. https://doi.org/10.1177/0333102417738202
20. Badakere A., Patil-Chhablani P. Orbital Apex Syndrome: A Review. Eye Brain. 2019;11:63–72. https://doi.org/10.2147/EB.S180190
21. Gatto F., Perez-Rivas L.G., Olarescu N.C., Khandeva P., Chachlaki K., Trivellin G. et al. Diagnosis and Treatment of Parasellar Lesions. Neuroendocrinology. 2020;110(9–10):728– 739. https://doi.org/10.1159/000506905
22. Iorga E.R., Costin D. Vascular emergencies in neuro-ophthalmology. Rom J Ophthalmol. 2020;64(4):323–332. https://doi.org/10.22336/rjo.2020.54
23. Adams H.P. Jr. Cerebral vasculitis. Handb Clin Neurol. 2014;119:475–94. https://doi.org/10.1016/B978-0-7020-4086-3.00031-X
24. Kedar S., Jayagopal L.N., Berger J.R. Neurological and Ophthalmological Manifestations of Varicella Zoster Virus. J Neuroophthalmol. 2019;39(2):220–231. https://doi.org/10.1097/WNO.0000000000000721
25. La Mantia L., Erbetta A., Bussone G. Painful ophthalmoplegia: an unresolved clinical problem. Neurol Sci. 2005;26 Suppl 2:s79–82. https://doi.org/10.1007/s10072-005-0414-9
26. Goadsby P.J. Raeder’s syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system. J Neurol Neurosurg Psychiatry. 2002;72(3):297–9. https://doi.org/10.1136/jnnp.72.3.297
27. Friedman D.I. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32(2):363–96. https://doi.org/10.1016/j.ncl.2014.01.001
28. Mendenhall W.M., Lessner A.M. Orbital pseudotumor. Am J Clin Oncol. 2010;33(3):304–6. https://doi.org/10.1097/COC.0b013e3181a07567
29. Yeşiltaş Y.S., Gündüz A.K. Idiopathic Orbital Infl ammation: Review of Literature and New Advances. Middle East Afr J Ophthalmol. 2018;25(2):71–80. https://doi.org/10.4103/meajo.MEAJO_44_18
30. Bahn R.S. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–38. https://doi.org/10.1056/NEJMra0905750
31. Hodgson N.M., Rajaii F. Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review. Ophthalmol Ther. 2020;9(1):21–33. https://doi.org/10.1007/s40123-019-00226-9
32. Raza H.K., Chen H., Chansysouphanthong T., Cui G. The aetiologies of the unilateral oculomotor nerve palsy: a review of the literature. Somatosens Mot Res. 2018;35(3-4):229–239. https://doi.org/10.1080/08990220.2018.1547697
33. Kline L.B., Hoyt W.F. The Tolosa–Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001;71(5):577–82. https://doi.org/10.1136/jnnp.71.5.577
34. Thu P.W., Chen Y.M., Liu W.M. Recurrent Tolosa–Hunt syndrome. Tzu Chi Med J. 2020;33(3):314–316. https://doi.org/10.4103/tcmj.tcmj_137_20
35. Carroll C.G., Campbell W.W. Multiple cranial neuropathies. Semin Neurol. 2009;29(1):53-65. https://doi.org/10.1055/s-0028-1124023
36. Smith J.R., Rosenbaum .JT. A role for methotrexate in the management of non-infectious orbital infl ammatory disease. Br J Ophthalmol. 2001;85(10):1220–4. https://doi.org/10.1136/bjo.85.10.1220
37. Kwon H.S., Kim T.Y., Kim J.H., Bae J.H., Koh S.H., Choi H. et al. Use of methotrexate in the management of recurrent Tolosa–Hunt syndrome: Two case reports. Medicine (Baltimore). 2020;99(17):e19882. https://doi.org/10.1097/MD.0000000000019882
Review
For citations:
Maksimova M.Yu., Illarioshkin S.N., Savizkaya I.A. Reccurent painful ophthalmoplegic neuropathy. Russian neurological journal. 2022;27(6):77-83. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-6-77-83